Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome
- Conditions
- Keratoconjunctivitis SiccaSjogren's SyndromeLupus Erythematosus, SystemicArthritis, RheumatoidScleroderma, Systemic
- Registration Number
- NCT00025818
- Lead Sponsor
- Allergan
- Brief Summary
A six-month clinical research trial to evaluate the effectiveness of an investigational medication for the treatment of dry eye syndrome in patients that have been diagnosed with moderate to severe dry eye syndrome, an autoimmune disorder AND/OR females 65 years of age or older.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 290
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (17)
UCLA
🇺🇸Los Angeles, California, United States
Indiana University
🇺🇸Indianapolis, Indiana, United States
Eyecare of La Jolla
🇺🇸La Jolla, California, United States
The Cole Eye Institute
🇺🇸Cleveland, Ohio, United States
Hunkleler Eye Center
🇺🇸Overland Park, Kansas, United States
Great Lakes Eye Institute
🇺🇸Saginaw, Michigan, United States
Northwest Cornea
🇺🇸Portland, Oregon, United States
Brandon Eye Clinic
🇺🇸Tampa, Florida, United States
Baylor College of Medicine
🇺🇸Houston, Texas, United States
Opticare
🇺🇸Waterbury, Connecticut, United States
UIC Eye Center
🇺🇸Chicago, Illinois, United States
Corona Research
🇺🇸El Paso, Texas, United States
Emory University
🇺🇸Atlanta, Georgia, United States
D'Ambrosio Eye Care
🇺🇸Leominster, Massachusetts, United States
Cornea Consultants of Albany
🇺🇸Albany, New York, United States
Dr. Wittpen's Office
🇺🇸Stony Brook, New York, United States
Dr. Freedman's Office
🇺🇸Brooklyn, New York, United States